DelveInsight's CLK Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

The study’s findings could influence AstraZeneca’s stock performance by providing valuable insights into treatment efficacy, potentially affecting investor sentiment. As the study progresses, it may ...

Market Implications: This study update could positively influence AstraZeneca’s stock performance and investor sentiment by showcasing the company’s commitment to advancing cancer treatments. As the ...

Despite challenges in the biopharma sector, Sophia Genetics SA (SOPH) showcases robust growth and strategic advancements in ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

AstraZeneca (AZ) has announced that Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) has been recommended by ...

Detailed price information for Astrazeneca Plc Ord (AZNCF) from The Globe and Mail including charting and trades.

Potential lumpiness in revenue due to milestone-based contracts was acknowledged by management.

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, ...

Antibody-drug conjugates are currently being investigated in more than 260 clinical trials.“It’s going to be the next novel ...

In this Healio video, Erica L. Mayer, MD, MPH, director of breast cancer clinical research at Dana-Farber Cancer Institute, discusses risk factors, treatment options and the importance of early cancer ...